About Index Trending news
Analyze
Top 50 Pricing
AngioChem

AngioChem

Work at AngioChem? Add yourself to this profile

AngioChem

AngioChem develops new drugs that are capable of crossing the blood-brain barrier to treat brain diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital
$3,000,000
Venture capital
$6,000,000
Employees

Team size

10+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when AngioChem makes some noise.